Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Refractory Nephrotic Syndrome in Children
NCT01716442Phase 3Unknown
- Sponsor
- Seoul National University Children's Hospital
- Start
- Aug 2012
- Primary completion
- Sep 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in nephrotic syndrome, sponsored by Seoul National University Children's Hospital. Status: unknown.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT01716442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716442.